80 related articles for article (PubMed ID: 9274533)
1. Evaluation of tumour angiogenesis as a prognostic marker in malignant mesothelioma.
Kumar-Singh S; Vermeulen PB; Weyler J; Segers K; Weyn B; Van Daele A; Dirix LY; Van Oosterom AT; Van Marck E
J Pathol; 1997 Jun; 182(2):211-6. PubMed ID: 9274533
[TBL] [Abstract][Full Text] [Related]
2. Angiogenic cytokines in mesothelioma: a study of VEGF, FGF-1 and -2, and TGF beta expression.
Kumar-Singh S; Weyler J; Martin MJ; Vermeulen PB; Van Marck E
J Pathol; 1999 Sep; 189(1):72-8. PubMed ID: 10451491
[TBL] [Abstract][Full Text] [Related]
3. WT1 mutation in malignant mesothelioma and WT1 immunoreactivity in relation to p53 and growth factor receptor expression, cell-type transition, and prognosis.
Kumar-Singh S; Segers K; Rodeck U; Backhovens H; Bogers J; Weyler J; Van Broeckhoven C; Van Marck E
J Pathol; 1997 Jan; 181(1):67-74. PubMed ID: 9072005
[TBL] [Abstract][Full Text] [Related]
4. Neurotensin expression and outcome of malignant pleural mesothelioma.
Alifano M; Loi M; Camilleri-Broet S; Dupouy S; Régnard JF; Forgez P
Biochimie; 2010 Feb; 92(2):164-70. PubMed ID: 19932148
[TBL] [Abstract][Full Text] [Related]
5. Does the degree of intratumoural microvessel density and VEGF expression have prognostic significance in osteosarcoma?
Ek ET; Ojaimi J; Kitagawa Y; Choong PF
Oncol Rep; 2006 Jul; 16(1):17-23. PubMed ID: 16786118
[TBL] [Abstract][Full Text] [Related]
6. EGFR expression: associations with outcome and clinicopathological variables in malignant pleural mesothelioma.
Edwards JG; Swinson DE; Jones JL; Waller DA; O'Byrne KJ
Lung Cancer; 2006 Dec; 54(3):399-407. PubMed ID: 17049671
[TBL] [Abstract][Full Text] [Related]
7. Angiogenesis is an independent prognostic factor in malignant mesothelioma.
Edwards JG; Cox G; Andi A; Jones JL; Walker RA; Waller DA; O'Byrne KJ
Br J Cancer; 2001 Sep; 85(6):863-8. PubMed ID: 11556838
[TBL] [Abstract][Full Text] [Related]
8. Lymphangiogenesis and angiogenesis in bladder cancer: prognostic implications and regulation by vascular endothelial growth factors-A, -C, and -D.
Miyata Y; Kanda S; Ohba K; Nomata K; Hayashida Y; Eguchi J; Hayashi T; Kanetake H
Clin Cancer Res; 2006 Feb; 12(3 Pt 1):800-6. PubMed ID: 16467091
[TBL] [Abstract][Full Text] [Related]
9. Thrombospondin-1 expression and clinical implications in malignant pleural mesothelioma.
Ohta Y; Shridhar V; Kalemkerian GP; Bright RK; Watanabe Y; Pass HI
Cancer; 1999 Jun; 85(12):2570-6. PubMed ID: 10375104
[TBL] [Abstract][Full Text] [Related]
10. Relation of microvessel density with microvascular invasion, metastasis and prognosis in renal cell carcinoma.
Yildiz E; Ayan S; Goze F; Gokce G; Gultekin EY
BJU Int; 2008 Mar; 101(6):758-64. PubMed ID: 18070177
[TBL] [Abstract][Full Text] [Related]
11. VEGF and VEGF type C play an important role in angiogenesis and lymphangiogenesis in human malignant mesothelioma tumours.
Ohta Y; Shridhar V; Bright RK; Kalemkerian GP; Du W; Carbone M; Watanabe Y; Pass HI
Br J Cancer; 1999 Sep; 81(1):54-61. PubMed ID: 10487612
[TBL] [Abstract][Full Text] [Related]
12. Expression of Maspin in non-muscle invasive bladder carcinoma: correlation with tumor angiogenesis and prognosis.
Friedrich MG; Toma MI; Petri S; Cheng JC; Hammerer P; Erbersdobler A; Huland H
Eur Urol; 2004 Jun; 45(6):737-43. PubMed ID: 15149745
[TBL] [Abstract][Full Text] [Related]
13. Expression and prognostic significance of hypoxia-inducible factor 1alpha (HIF-1alpha) in malignant pleural mesothelioma (MPM).
Klabatsa A; Sheaff MT; Steele JP; Evans MT; Rudd RM; Fennell DA
Lung Cancer; 2006 Jan; 51(1):53-9. PubMed ID: 16169121
[TBL] [Abstract][Full Text] [Related]
14. Tumour angiogenesis and mast cell density in the prognostic assessment of colorectal carcinomas.
Acikalin MF; Oner U; Topçu I; Yaşar B; Kiper H; Colak E
Dig Liver Dis; 2005 Mar; 37(3):162-9. PubMed ID: 15888280
[TBL] [Abstract][Full Text] [Related]
15. Value of morphometry, texture analysis, densitometry, and histometry in the differential diagnosis and prognosis of malignant mesothelioma.
Weyn B; Van De Wouwer G; Koprowski M; Van Daele A; Dhaene K; Scheunders P; Jacob W; Van Marck E
J Pathol; 1999 Dec; 189(4):581-9. PubMed ID: 10629562
[TBL] [Abstract][Full Text] [Related]
16. Expression of vascular endothelial growth factor in malignant mesothelioma.
Aoe K; Hiraki A; Tanaka T; Gemba K; Taguchi K; Murakami T; Sueoka N; Kamei T; Ueoka H; Sugi K; Yoshino T; Kishimoto T
Anticancer Res; 2006; 26(6C):4833-6. PubMed ID: 17214348
[TBL] [Abstract][Full Text] [Related]
17. Prospective study of intratumoral microvessel density, p53 expression and survival in colorectal cancer.
Vermeulen PB; Van den Eynden GG; Huget P; Goovaerts G; Weyler J; Lardon F; Van Marck E; Hubens G; Dirix LY
Br J Cancer; 1999 Jan; 79(2):316-22. PubMed ID: 9888475
[TBL] [Abstract][Full Text] [Related]
18. Clinico-pathological and biological prognostic factors in pleural malignant mesothelioma.
O'Byrne KJ; Edwards JG; Waller DA
Lung Cancer; 2004 Aug; 45 Suppl 1():S45-8. PubMed ID: 15261433
[TBL] [Abstract][Full Text] [Related]
19. Two distinct types of blood vessels in clear cell renal cell carcinoma have contrasting prognostic implications.
Yao X; Qian CN; Zhang ZF; Tan MH; Kort EJ; Yang XJ; Resau JH; Teh BT
Clin Cancer Res; 2007 Jan; 13(1):161-9. PubMed ID: 17200351
[TBL] [Abstract][Full Text] [Related]
20. Morbidity, mortality, mean survival, and the impact of histology on survival after pleurectomy in 64 patients with malignant pleural mesothelioma.
Neragi-Miandoab S; Richards WG; Sugarbaker DJ
Int J Surg; 2008 Aug; 6(4):293-7. PubMed ID: 18585112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]